SAN ANTONIO, TX, June 14, 2018 /CNW/ - Alternate Health Corp., ( 'Alternate Health' or the 'Company' ) (CSE: AHG) (OTCQB: AHGIF), an international leader in software solutions for the medical cannabis industry, is pleased to announce that Jeff Langenbach has been appointed to the Company's Board of Directors.
Mr. Langenbach has over 25 years of experience in management, finance, corporate development, and mergers and acquisitions. In addition to his financial expertise, Mr. Langenbach will strengthen the Board's international perspective, with his significant experience managing business activity in over 30 countries, spanning six continents.
"This is an exciting new addition to the Company's Board of Directors," says Dr. Michael Murphy, Chairman and CEO of Alternate Health. "Jeff's experience and expertise comes at a key moment for the Company, as we ramp up our operations across all our verticals."
Mr. Langenbach spent 12 years on Wall Street with DLJ, CS-First Boston, and Credit Suisse, raising debt and equity capital, advising on M&A transactions and helping form joint ventures. During this period, he helped raise over $10 billion, advised on numerous cross-border M&A assignments and participated in over 20 IPOs.
For the past 10 years, Mr. Langenbach has been part of the senior management team at Vanta Education (FKA Apollo Education Group). Mr. Langenbach led the formation of Apollo Global, an international subsidiary, which had worldwide operations in Australia, Brazil, Chile, South Africa, Germany, Mexico, the UK, India, and the United States, with revenues exceeding $500 million.
"As one of the earliest investors in Alternate Health, Jeff has been a committed and long-term supporter of the Company from day one," says Dr. Murphy. "We are confident his appointment will strengthen the Board's representation of shareholder and investor interests."
Mr. Langenbach's education includes a Master's Degree in Management from the Kellogg School of Management at Northwestern University and a Bachelor's Degree in Business Administration from the University of Wisconsin-Madison.
Company Updates and Insider Buying
As discussed during a recent shareholder call, Alternate Health will be releasing an update to investors within the next seven to 10 days. Dr. Murphy, Chairman and CEO, will provide insight on the Company's operations and ongoing strategy in a letter to shareholders.
About Alternate Health
Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company's other verticals. This sophisticated cross-integration of the company's enterprises has positioned Alternate Health as one of the only cannabis companies that delivers consistent revenue and intellectual property without growing, manufacturing or distributing the cannabis plant. Through its software solutions, data analytics, and patented delivery systems, Alternate Health's goal is to be the global authority on scientific and clinical support for cannabis in regulated markets. Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.
Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals, AXIM Biotechnologies Inc., Canopy Growth Corporation, and Aphria Inc. Alternate Health is differentiated from other cannabis companies by its focus on ancillary services for patients, healthcare professionals and regulatory providers rather than selling a commodity. For more information about Alternate Health Corp., visit www.alternatehealth.com.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects, financing plans and spin off plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.